Display options
Cite
De La Mata D, Espi MG, Carreras J, et al. Molecular Imaging FDG-PET/CT Response to Neoadjuvant Oxaliplatin and Chemoradiation in Rectal Cancer as Prognostic Factor in Surveillance. Pract Radiat Oncol. 2013;3(2):S12doi: 10.1016/j.prro.2013.01.040.
De La Mata, D., Espi, M. G., Carreras, J., Alvarez, E., & Calvo, F. (2013). Molecular Imaging FDG-PET/CT Response to Neoadjuvant Oxaliplatin and Chemoradiation in Rectal Cancer as Prognostic Factor in Surveillance. Practical radiation oncology, 3(2), S12. https://doi.org/10.1016/j.prro.2013.01.040
De La Mata, D, et al. "Molecular Imaging FDG-PET/CT Response to Neoadjuvant Oxaliplatin and Chemoradiation in Rectal Cancer as Prognostic Factor in Surveillance." Practical radiation oncology vol. 3,2 (2013): S12. doi: https://doi.org/10.1016/j.prro.2013.01.040
De La Mata D, Espi MG, Carreras J, Alvarez E, Calvo F. Molecular Imaging FDG-PET/CT Response to Neoadjuvant Oxaliplatin and Chemoradiation in Rectal Cancer as Prognostic Factor in Surveillance. Pract Radiat Oncol. 2013 Apr-Jun;3(2):S12. doi: 10.1016/j.prro.2013.01.040. Epub 2013 Mar 25. PMID: 24674478.
Copy Download .nbib Format: NLM
Share it on

Pract Radiat Oncol. 2013 Apr-Jun;3(2):S12. doi: 10.1016/j.prro.2013.01.040. Epub 2013 Mar 25.

Molecular Imaging FDG-PET/CT Response to Neoadjuvant Oxaliplatin and Chemoradiation in Rectal Cancer as Prognostic Factor in Surveillance.

Practical radiation oncology

D De La Mata, M Gomez Espi, J Carreras, E Alvarez, F Calvo

Affiliations

  1. H.G.U. Gregorio Marañón, MADRID, Spain.

PMID: 24674478 DOI: 10.1016/j.prro.2013.01.040

[No abstract available.]

Publication Types